Serum creatine phosphokinase levels and prednisone treated muscle weakness.
Evidence is cited from the literature and from personal experience with the "inflammatory" form of facioscapulohumeral syndrome that the creatine phosphokinase reduction occurring during pharmacologic treatment of various neuromuscular diseases does not necessarily imply therapeutic benefit.
D000293:Adolescent; D000328:Adult; D003402:Creatine Kinase / Q000097:blood*; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D009220:Myositis / Q000188:drug therapy* / Q000201:enzymology; D011241:Prednisone / Q000627:therapeutic use*; D013577:Syndrome
D003402:Creatine Kinase; D011241:Prednisone